Durvalumab vs Irbesartan

Durvalumab vs Irbesartan: Overview

This comparison examines the pharmacological differences between Durvalumab and Irbesartan.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Irbesartan: Selective non-competitive angiotensin II type 1 receptor antagonist.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Irbesartan — 11-15 hours.

Chemical Properties

Molecular Formula: Irbesartan — C25H28N6O.

Molecular Weight: Irbesartan — 428.5320 g/mol.

Type: Durvalumab — Antibody; Irbesartan — Small molecule.